SGMO Sangamo Therapeutics, Inc.

NEUTRAL Impact: 3/10 PRESS-RELEASE
Horizon days Filed Mar 19, 2026 Processed 2mo ago Wire GlobeNewswire
Press release: earnings
Latest settled — T+20d
SGMO ▼ -18.18% at T+20d
NEUTRAL call ✗ call lost -18.18% · α vs SPY -27.50% · entry $0.3300 → $0.2700
Next anchor: T+60d tomorrow
Currently $0.1500 · -54.55% from $0.3300 entry
Entry anchored
Mar 19, 03:59 PM ET
via Databento tick
T+1d
+3.03%
call +3.03% · α +1.93%
$0.3400
settled 3mo ago
T+5d
-3.03%
call -3.03% · α -0.88%
$0.3200
settled 3mo ago
T+20d
-18.18%
call -18.18% · α -27.50%
$0.2700
settled 8w ago
T+60d
call — · α —
tomorrow

Price Chart

Loading chart...

Executive Summary

Sangamo Therapeutics announced it will release its Q4 and full-year 2025 financial results on March 30, 2026, followed by a conference call to review the results and provide business updates. The press release contains no actual financial data, only logistical details about the earnings announcement.

Actionable Insight

Traders should monitor the March 30 earnings call for updates on revenue, R&D progress, cash runway, and pipeline developments, which could move the stock given the company's small market cap ($121M).

Key Facts

  • Sangamo Therapeutics will release Q4 and full-year 2025 financial results after market close on March 30, 2026.
  • A conference call is scheduled for 4:30 p.m. Eastern on the same day to discuss results and business updates.
  • No financial figures, guidance, or operational updates were disclosed in this press release.

Financial Impact

No financial data disclosed — impact will depend on actual earnings release

Risk Factors

  • High volatility expected post-earnings due to small market cap and lack of current revenue-generating products.
  • No financial or operational metrics provided in this release — actual results may differ significantly from expectations.

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3259419
4 reports for SGMO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SGMO — sortable, filterable
Type Now
Apr 29, 2026
6w ago
8-K
BEARISH ★ 8/10
$0.1300 $0.2000▼ −53.85%▼ −48.39%$0.1500 (−15.38%)
Apr 21, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$0.2600 $0.1300▼ −50.00%▼ −54.91%$0.1500 (−42.31%)
Mar 30, 2026
10w ago
Press Release
MIXED ★ 6/10
$0.2500 $0.1387▼ −44.52%▼ −53.94%$0.1500 (−40.00%)
Mar 19, 2026
12w ago
Press Release
NEUTRAL ★ 3/10
$0.3300 $0.2700▼ −18.18%▼ −27.50%$0.1500 (−54.55%)
Showing 4 of 4

US Market Status

Market Closed — Opens Mon (49h 15m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access